RxDoctor Payments Data

Stephen Beck, MD

Urology · Lafayette, INNPI 1326034745

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $444, 8.2 times the $54 reported in 2019. That places this record below the midpoint for urology clinicians in IN, where the typical reported total is $3,350.

$1,473in general payments, 2019–2025

Across 91 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cumberland Pharmaceuticals, Inc.$294
  • Bioprotect Medical, Inc.$165
  • Medtronic$157
  • Takeda Pharmaceuticals U.S.A., Inc.$153
  • Boston Scientific$150
  • Axonics, Inc.$91
  • plus $463 from 17 others

What the payments were for

  • Food & beverage$1,473100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,473 in reported general payments places this provider in the 30th percentile of 272 urology providers in Indiana.

See all urology providers in Indiana →

Medicare billing

Part B allowed, 2024
$94,133
Medicare patients
250
Services billed
816

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron19$9,932
Tamsulosin Hcl412$4,899
Oxybutynin Chloride ErOxybutynin Chloride51$1,807
Finasteride84$778
Solifenacin Succinate34$562
NitrofurantoinNitrofurantoin Macrocrystal24$491
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen47$480
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst44$381
Testosterone Cypionate13$326
Ciprofloxacin Hcl55$240
Amitriptyline Hcl16$154
Amlodipine Besylate24$129
Furosemide14$123
Levothyroxine Sodium13$107
Rosuvastatin Calcium13$96

Paid to pharmacies, not to this prescriber.

Other urology in Lafayette

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →